NO20005586D0 - Genomiske sekvenser oppströms for den kodende regionen til G- CSF genet for produksjon og levering av protein - Google Patents

Genomiske sekvenser oppströms for den kodende regionen til G- CSF genet for produksjon og levering av protein

Info

Publication number
NO20005586D0
NO20005586D0 NO20005586A NO20005586A NO20005586D0 NO 20005586 D0 NO20005586 D0 NO 20005586D0 NO 20005586 A NO20005586 A NO 20005586A NO 20005586 A NO20005586 A NO 20005586A NO 20005586 D0 NO20005586 D0 NO 20005586D0
Authority
NO
Norway
Prior art keywords
delivery
coding region
protein production
genomic sequences
sequences upstream
Prior art date
Application number
NO20005586A
Other languages
English (en)
Other versions
NO20005586L (no
Inventor
Douglas A Treco
Michael W Heartlein
Richard F Selden
Original Assignee
Transkaryotic Therapies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transkaryotic Therapies Inc filed Critical Transkaryotic Therapies Inc
Publication of NO20005586D0 publication Critical patent/NO20005586D0/no
Publication of NO20005586L publication Critical patent/NO20005586L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20005586A 1998-05-07 2000-11-06 Genomiske sekvenser oppströms for den kodende regionen til G- CSF genet for produksjon og levering av protein NO20005586L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8464998P 1998-05-07 1998-05-07
PCT/US1999/009924 WO1999057291A1 (en) 1998-05-07 1999-05-05 Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery

Publications (2)

Publication Number Publication Date
NO20005586D0 true NO20005586D0 (no) 2000-11-06
NO20005586L NO20005586L (no) 2001-01-03

Family

ID=22186313

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005586A NO20005586L (no) 1998-05-07 2000-11-06 Genomiske sekvenser oppströms for den kodende regionen til G- CSF genet for produksjon og levering av protein

Country Status (18)

Country Link
US (2) US6242218B1 (no)
EP (1) EP1075530A1 (no)
JP (1) JP2002513579A (no)
KR (1) KR20010071207A (no)
CN (1) CN1308680A (no)
AR (1) AR016263A1 (no)
AU (1) AU762969B2 (no)
CA (1) CA2328476A1 (no)
CZ (1) CZ299460B6 (no)
GC (1) GC0000172A (no)
HU (1) HUP0101355A3 (no)
IL (1) IL139431A0 (no)
NO (1) NO20005586L (no)
NZ (1) NZ507451A (no)
PL (1) PL344391A1 (no)
TR (1) TR200003272T2 (no)
WO (1) WO1999057291A1 (no)
ZA (1) ZA200005744B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1647501A (en) 1999-12-10 2001-06-18 Cytos Biotechnology Ag Replicon based activation of endogenous genes
JP2002017357A (ja) * 2000-07-04 2002-01-22 Calpis Co Ltd アンカーペプチド、融合蛋白質、及び蛋白質の固定化方法
US20030082511A1 (en) * 2001-09-25 2003-05-01 Brown Steven J. Identification of modulatory molecules using inducible promoters
US20040071686A1 (en) 2002-04-25 2004-04-15 Treco Douglas A. Treatment of alpha-galactosidase A deficiency
NZ548256A (en) * 2004-02-02 2010-02-26 Ambrx Inc Modified human four helical bundle polypeptides and their uses
US20090263900A1 (en) 2008-04-14 2009-10-22 Sangamo Biosciences, Inc. Linear donor constructs for targeted integration
RU2009141965A (ru) 2007-04-16 2011-05-27 Момента Фармасьютикалз, Инк. (Us) Определенные продукты гликопротеина и способы их производства
CN103965347B (zh) 2007-05-02 2017-07-18 Ambrx公司 经修饰干扰素β多肽和其用途
NZ602170A (en) 2008-02-08 2014-03-28 Ambrx Inc Modified leptin polypeptides and their uses
PT2318029T (pt) 2008-07-23 2018-01-10 Ambrx Inc Polipéptidos de g-csf bovino modificados e suas utilizações
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733761A (en) 1991-11-05 1998-03-31 Transkaryotic Therapies, Inc. Protein production and protein delivery
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery

Also Published As

Publication number Publication date
KR20010071207A (ko) 2001-07-28
WO1999057291A1 (en) 1999-11-11
NO20005586L (no) 2001-01-03
AR016263A1 (es) 2001-06-20
EP1075530A1 (en) 2001-02-14
HUP0101355A2 (hu) 2001-08-28
CZ20003807A3 (cs) 2001-04-11
TR200003272T2 (tr) 2001-03-21
US20030022850A1 (en) 2003-01-30
AU3788799A (en) 1999-11-23
PL344391A1 (en) 2001-11-05
NZ507451A (en) 2003-12-19
HUP0101355A3 (en) 2003-08-28
CZ299460B6 (cs) 2008-08-06
AU762969B2 (en) 2003-07-10
US6242218B1 (en) 2001-06-05
IL139431A0 (en) 2001-11-25
GC0000172A (en) 2006-03-29
CA2328476A1 (en) 1999-11-11
JP2002513579A (ja) 2002-05-14
ZA200005744B (en) 2001-05-16
CN1308680A (zh) 2001-08-15

Similar Documents

Publication Publication Date Title
DE69917716D1 (de) Protein-deamiderendes Enzym, dafür kodierendes Gen, Verfahren zur Herstellung und Verwendung davon
DE60021160D1 (de) Protein-deamiderendes Enzym, dafür kodierendes Gen, enzym-produzierendes Mikroorganismus, Verfahren zur Herstellung und Verwendung davon
AU2003257009A8 (en) System and method for the distribution of digital products
HUP0200480A3 (en) Enzymes of the biosynthetic pathway for the production of triacylglycerol and recombinant dna molecules encoding these enzymes
NO20005586D0 (no) Genomiske sekvenser oppströms for den kodende regionen til G- CSF genet for produksjon og levering av protein
NO973685L (no) Multi-tumor avvikende vekstgener
IL147138A0 (en) Methods of and pharmaceutical compositions for modulating cell adhesion, migration and extravasation
FI940203L (fi) Geeni, joka koodaa eikosapeutaanihappoa syntetisoivia entsyymejä, ja menetelmä eikospentaanihapon valmistamiseksi
WO1999051727A3 (de) Menschliche nukleinsäuresequenzen aus ovarnormalgewebe
DE69534685D1 (de) Transferase und amylase, verfahren zur herstellung dieser enzyme, ihre verwendung und für die kodierende gene
DE60336235D1 (de) Balkenartiger verbindungsanschluss des steckertyps und verfahren zu seiner herstellung
IS5742A (is) Aðferð til genalækninga
NO20005587D0 (no) Genomiske sekvenser for produksjon og levering av protein
MX9806041A (es) Proteina purificada sr-p70.
NO20005585L (no) Genomiske sekvenser oppströms for den kodende regionen til IFN-ALPHA2 genet for produksjon og levering av protein
EP1551972A4 (en) NUCLEIC ACIDS, POLYPEPTIDES, SINGLE NUCLEOTIDE POLYMORPHISMS AND METHOD OF USE THEREOF
AU6795201A (en) Nucleic acid sequences and methods for the modification of plant gene expression
HK1034994A (en) Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery
AU3937101A (en) Purified polynucleotide sequences of plants and yeast coding for proteins interacting with the products of geminivirus genome
ZA200005747B (en) Genomic sequences upstream of the coding region of the IFN-Alpha2 gene for protein production and delivery.
DE19983297T1 (de) Gene, die für beta-Agarasen kodieren, und ihre Verwendung zur Herstellung von Enzymen für den biologischen Abbau von Agar
HK1034745A (en) Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery
EP1174503A4 (en) NOVEL PROTEINS, GENES ENCODING THEM AND METHODS OF USE
AU2001268108A1 (en) Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
AU2001292326A1 (en) Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application